Vanda Pharma (VNDA) Tops by 3c, Posts Q3 Loss of $0.28
VNDA Hot Sheet
Revenue Growth %: +8.5%Financial Fact:
Net income (loss): -7.96M
Today's EPS Names:
SAPX, ECTY, TRNS, More
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reports Q3 loss of $0.28, 3 cents better than the analyst estimate of ($0.31).
You May Also Be Interested In
- UPDATE: Lowe's (LOW) Beats Q1 Views Amid Lagging Seasonal Demand; Issues Light FY12 Earnings Outlook
- Campbell Soup Co. (CPB) Beats Q3 Views; Offers Mixed FY12 Guidance
- Daqo New Energy (DQ) Posts Q1 Loss of 39c/Share; Guides Q2 Shipments
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
